MediDrive Unveils Groundbreaking Transportation Management System (TMS) for the Healthcare Industry

BROOKLYN, N.Y., Sept. 12, 2024 /PRNewswire/ — MediDrive, a leading Non-Emergency Medical Transportation (NEMT) company, has launched a revolutionary Transportation Management System (TMS) designed to transform how the healthcare industry manages patient transportation. The new system allows health plans, physician groups, hospitals, treatment facilities, and Flex Card administrators to seamlessly find and book the most suitable transportation options tailored to the specific needs of their members and patients.

We’re reimagining NEMT. Our new Transportation Management System is a game-changer. -Alan J Murray, President, MediDrive

“We are reimagining NEMT. When you compare most NEMT suppliers, they are basically the same with varying degrees of performance. At MediDrive, we want to be much more than that and we believe this new Transportation Management System is a game-changer,” said Alan Murray, President and CEO of MediDrive.

Addressing a critical aspect of the Social Determinants of Health (SDoH), MediDrive TMS aims to alleviate the transportation challenges that often prevent patients from attending medical appointments. With 20% of Americans missing medical appointments due to transportation issues, resulting in an annual loss of $150 billion, MediDrive’s solution is both timely and impactful. As the healthcare industry increasingly recognizes the link between transportation access and health outcomes, many are seeking reliable transportation solutions to ensure patients can access necessary care.

MediDrive’s TMS platform empowers its users to access and manage multiple transportation suppliers within a single, user-friendly interface. The system enables users to set preferences based on patient needs, such as vehicle type, cost, availability, and proximity offering a one-stop solution for booking the best transportation options. For health plans that means their members get the most value from the transportation benefits the plans already offer. For health providers that means controlling patient transportation costs while ensuring that their patients are compliant with the treatments that they are providing resulting in the better outcomes.

“At its core, our TMS is a logistics platform integrated into a marketplace,” Murray added. “Healthcare providers can quickly create an account, configure their options, and start booking transportation in under 10 minutes, with no long-term commitments or startup fees. Health plans can easily integrate their traditional transportation benefits or their Flex Card programs with the TMS platform.”

Calve Miligan, Chief Revenue Officer at MediDrive, added, “Our intuitive website allows users to choose transportation based on cost and proximity, ensuring they select the best option with just one click. Once booked, the car is immediately on its way.”

MediDrive’s TMS also expands beyond traditional ride-share offerings, providing access to a wide range of vehicle types, including ambulatory, wheelchair-accessible, two-person assist, stretcher, and VIP white-glove service. The system also allows users to specify special patient support requirements, such as wheelchair access or advanced life support, ensuring comprehensive care.

Every ride booked through MediDrive’s TMS benefits from the company’s proprietary AI routing and tracking technology. This advanced software utilizes real-time routing, dispatch, and tracking, ensuring timely pickups, drop-offs, and overall ride progress monitoring. If a delay occurs, the system automatically reroutes to maintain the highest on-time performance standards in the industry.

Circadian Health Among Early Adopters

Circadian Health, a multi-specialty care provider in cardiology, endocrinology, sleep, and pulmonology, is one of the first organizations to implement MediDrive’s TMS.

“The TMS system is an ideal solution for our patients who face transportation and other SDOH challenges. It allows us to send patients to primary care, specialists, or the lab as needed. This system helps us keep patients out of the hospital and thriving at home,” said Chuck Hector, President and Co-Founder of Circadian Health. “Patients with transportation issues often resort to dialing 911 for emergency transportation, which is often unnecessary and costly. Through this partnership, we reduce concerns and anxiety for patients. MediDrive’s platform ensures they arrive on time, comfortably, and cost-effectively.”

With the official rollout of MediDrive TMS in September, additional healthcare providers are expected to join, benefiting from this innovative solution to patient transportation.
To see the TMS  platform in action (Click Here)

About MediDrive
MediDrive is dedicated to enhancing the health and well-being of Americans by providing compassionate, reliable transportation to medical appointments. Specializing in Non-Emergency Medical Transportation (NEMT), MediDrive combines advanced technology with exceptional service to address the complexities of patient transportation, a key social determinant of health. Serving Medicare Advantage, Medicaid, and various healthcare provider programs nationwide, MediDrive is committed to delivering top-tier on-time performance and customer satisfaction through its AI-driven, scalable platform.

For more information, visit www.MediDrive.com
For current updates MediDrive on LinkedIn

About Circadian Health
Circadian is the first and only virtual-first cardiometabolic provider in the United States and delivers integrated hospital-at-home programs with an interoperable technology approach for the management of complex cardiometabolic disease.

For more information, visit www.circadiancare.com.

For more information, press only:
Jim Tenny
MediDrive
917-520-3614
jim.tenny@medidrive.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/medidrive-unveils-groundbreaking-transportation-management-system-tms-for-the-healthcare-industry-302247877.html

SOURCE MediDrive

Staff

Recent Posts

Masimo Partners with Qualcomm to Develop Next-Generation Smartwatch Reference Platform for Original Equipment Manufacturers

Comprehensive Platform Combines Masimo’s Industry-leading Biosensing Capabilities with Snapdragon Wearable Platforms to Expand the Wear…

11 hours ago

Medigene Presents Progress on KRAS Library and UniTope & TraCR Technology at ESMO 2024

Planegg/Martinsried, September 14, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an…

17 hours ago

KFSHRC Revolutionizes Patient Care with Pioneering Experience Ambassadors Program

RIYADH, Saudi Arabia, Sept. 14, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research…

17 hours ago

Cullinan Therapeutics Presents Positive Updated Data from Module C of Zipalertinib Pivotal Phase 2b Study at ESMO 2024

Updated data show consistent objective response rate of 40% and manageable safety profile in patients…

17 hours ago

RYBREVANT®▼ (amivantamab) plus chemotherapy shows positive overall survival trend versus chemotherapy in patients with previously treated EGFR-mutated lung cancer

Post-progression outcomes showed significant and sustained improvement for amivantamab plus chemotherapy versus chemotherapy alone1 BEERSE,…

17 hours ago